Systematic Reviews to Underpin the Development of a Generic Blood Test for Cancer

Cancer Research UK


  • Prof Ian Cree (UHCW)
  • Prof Ala Szczepura (Coventry University)
  • Dr Sian Taylor-Phillips
  • Prof Annie Young (Warwick University)
  • Dr Dawn Teare
  • Dr Sophie Whyte (ScHARR)
  • Dr Gozde Ozakinci (St Andrews University) for the Early Cancer Detection Consortium (ECDC)

Detection of very early cancerous changes has the capacity to save many lives and reduce the burden of disease for cancer patients and treatment costs for healthcare systems. This is the vision of the Early Cancer Detection Consortium. Building on recent technological developments, we aim to develop a blood-based screening test for multiple tumour types so that most cancer patients can be cured without experiencing any of the symptoms of cancer or the side effects of treatment. Systematic reviews and economic modelling are underway to underpin future advances.

 Queen’s Award for Enterprise Logo
University of the year shortlisted
QS Five Star Rating 2023